ClinicalTrials.Veeva

Menu

Expressing Personal Recollections in English or Spanish to Alleviate Traumatic Emotions (Exprésate)

University of Miami logo

University of Miami

Status

Completed

Conditions

Post Traumatic Stress Disorder

Treatments

Behavioral: Weekly Emotional Disclosure (WED)

Study type

Interventional

Funder types

Other

Identifiers

NCT05090839
20190760

Details and patient eligibility

About

The purpose of this study is to test if expressive writing about traumatic events has positive changes in women living with post-traumatic stress.

Enrollment

40 patients

Sex

Female

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age ≥ 21 years
  2. Elevated PTSD symptoms as assessed by the Post-Traumatic Stress Disorder Checklist Scale-Version DSM 5 (PCL-5) using a cut-off of 34 or above
  3. On a stable anti-retroviral therapy regimen for > 6 months as assessed with the Adult AIDS Clinical Trial Group structured interview
  4. Spanish-English bilingual as measured by the Brief Acculturation Scale for Hispanics (cut-off of 3), Spanish speaker or English speaker
  5. Participant is willing and able to sign Informed Consent Form (ICF)
  6. self-report as Latina
  7. HIV positive serostatus as determined by medical record within the last 12 months
  8. Born female.

Exclusion criteria

  1. Left-handedness or ambidextrous
  2. Inability to tolerate the scanning procedures
  3. Metal in body or prior history working with metal fragments
  4. Any other contraindications for MRI examination (e.g., metallic implants such as pacemakers, surgical aneurysm clips, or known metal fragments embedded in the body)
  5. currently pregnant or could be pregnant
  6. Heavy alcohol intake (> 3 drinks) within 12 hours prior to participation in Functional Magnetic Resonance Imaging (fMRI)
  7. Evidence from health history of neurological or systemic disorder which can cause cognitive impairment
  8. Self-reported current diagnosis of psychiatric disorder or psychoactive substance abuse or dependence
  9. Recent history (within two years) of myocardial infarction
  10. Severe cardiovascular disease, or currently active cardiovascular disease (e.g., angina, cardiomyopathy)
  11. Uncontrolled hypertension or hypotension
  12. History of closed trauma with loss of consciousness
  13. Space occupying lesions (e.g., mass lesions, tumors)
  14. Central Nervous System (CNS) infection
  15. CNS vasculitis
  16. CNS demyelinating disease (e.g., multiple sclerosis)
  17. Congenital CNS abnormality (e.g., cerebral palsy)
  18. Seizure disorders
  19. History of cerebrovascular disease (e.g., stroke, TIA's)

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Spanish-Only Writing Group
Active Comparator group
Description:
Participants in this group will be required to write once weekly for 4 consecutive weeks. Participants will be instructed to write objectively about what they did the day prior and to avoid writing about their emotions or opinions. The participant will be required to write in their preferred language (English or Spanish).
Treatment:
Behavioral: Weekly Emotional Disclosure (WED)
English-Only Writing Group
Experimental group
Description:
Participants in this group will be asked to write about their most traumatic or upsetting experiences for a total of 4 sessions (one session a week for 4 consecutive weeks). The participant will be required to write in their preferred language (English or Spanish).
Treatment:
Behavioral: Weekly Emotional Disclosure (WED)

Trial contacts and locations

1

Loading...

Central trial contact

Roger McIntosh

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems